Proposition de loi pour une politique du médicament plus prévisible, plus innovante et plus souveraine

This is an ordinary bill (proposition de loi) tabled in the French National Assembly during the 17th legislature. Its title indicates it aims to make France's medicines policy more predictable, more innovative and more sovereign, meaning less dependent on foreign supply chains for drugs. The metadata does not give the detailed measures, so the specific content is not known from this information alone. Based on the title alone, the bill would most likely concern pharmaceutical companies, healthcare providers, patients and the national health system. Its practical effects on prices, approvals, research incentives or supply security cannot be determined from metadata; the full text would be needed.